LPAR3 and posterior cortical atrophy: Importantly, PCa-bearing nude mice treated with Ki16425—a LPA1/LPA3 pharmacological antagonist—exhibited a significant reduction in the intratumor lymphatic vessel density and lymph node metastasis rate, compared with PCa-bearing mice treated with vehicle [88].